Highlights in Non-Small Cell Lung Cancer From ASCO 2020 Highlights in Non-Small Cell Lung Cancer From ASCO 2020

Dr Mark Kris reports on key studies in NSCLC from ASCO 2020, including the practice-changing ADAURA trial, results on an antibody-drug conjugate targeting HER2, and data on a new checkpoint inhibitor.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news